Ascentage Pharma GR-ADRAAPG
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 12 institutions reported holding Ascentage Pharma GR-ADR (AAPG) in their 13F filings, down 2 from Q3 2025. 2 opened new positions and 3 sold out. The largest holders were Point72 Asset Management ($439K), XY Capital Ltd ($358K) and Citadel Advisors ($255K). 2 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Ascentage Pharma GR-ADR
- CUSIP
- 04390B105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $439K |
| Exits | 3 | $1.0M |
All 13F filers, Q3 2025 → Q4 2025: 16,921 shares bought and 45,297 shares sold, net −28,376 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Point72 Asset Management | 0.00% | New | 16,726 | $439K |
| XY Capital Ltd | 0.36% | Reduce -24.8% | 13,628 | $358K |
| Citadel Advisors | 0.00% | Add +0.9% | 9,737 | $255K |
| UBS Group AG | 0.00% | Reduce -76.9% | 4,232 | $111K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | Add +3.4% | 2,546 | $67K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -72.3% | 230 | $6K |
| Osaic Holdings, Inc. | 0.00% | No change | 220 | $6K |
| Bank of America Corp. | 0.00% | Add +11.7% | 201 | $5K |
| Morgan Stanley | 0.00% | Reduce -24.6% | 153 | $4K |
| Bell Investment Advisors, Inc | 0.00% | No change | 67 | $2K |
| EverSource Wealth Advisors, LLC | 0.00% | Reduce -64.2% | 24 | $630 |
| Royal Bank of Canada | 0.00% | New | 6 | $0 |
"% of holder's portfolio" is AAPG's weight in each manager's 13F, not the share of Ascentage Pharma GR-ADR the manager owns.